title: Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease.
abstract: BACKGROUND
  Carbohydrate deficient transferrin (CDT), a biochemical marker of chronic alcohol consumption, is used by researchers and clinicians alike in a variety of populations. Levels of CDT may be affected by certain types of medical illnesses and conditions. Thus the interpretation of CDT results may need to be carefully examined in these populations. Because CDT is synthesized, glycosylated, and secreted by the liver, the use of CDT values in patients with liver disease has been an area of focused interest.
  
  
  METHODS
  We evaluated the CDT values of 79 abstaining patients with end-stage liver disease. These patients were recruited from a liver transplant clinic while they were listed and waiting for transplantation. Patients were determined to be abstaining both by interview and by random blood alcohol levels in those with a diagnosis of alcoholic liver disease. The severity of the liver disease was categorized by the Child-Pugh score. Correlations were determined between CDT values and liver enzymes, and Child-Pugh scores and liver diagnosis.
  
  
  RESULTS
  Nearly 50% of the patients had a CDT value of 2.6% or above, indicating a clinically positive value. There were strong correlations between CDT and a number of biochemical and physical variables, most importantly the Child-Pugh score (r = 0.52, p = 0.000). Specific liver diseases were not associated with absolute CDT values. However, patients with hepatitis C (HCV) had a significantly higher chance of having a clinically positive CDT compared with patients with other types of liver diseases.
  
  
  CONCLUSIONS
  These results suggest that an elevated CDT value may not accurately represent alcohol consumption in patients with advanced liver disease. In fact, in such patients, the CDT may become a marker for the degree of liver impairment in alcoholic and nonalcoholic liver disease. CDT values should be viewed with caution in any patient with liver disease especially when the degree of cirrhosis reaches a Child-Pugh score of C (total score of 10 or above).
authors.affiliation: University of Pittsburgh Medical Center, Western Psychiatric Institute and Clinics, Pittsburgh, Pennsylvania 15213, USA. dimartiniaf@msx.upmc.edu
authors.forename: A
authors.initials: A
authors.lastname: DiMartini
authors.forename: N
authors.initials: N
authors.lastname: Day
authors.forename: T
authors.initials: T
authors.lastname: Lane
authors.forename: A T
authors.initials: AT
authors.lastname: Beisler
authors.forename: M A
authors.initials: MA
authors.lastname: Dew
authors.forename: R
authors.initials: R
authors.lastname: Anton
mesh_terms: D000428:Alcohol Drinking / Q000097:blood; D000437:Alcoholism / Q000097:blood* / Q000628:therapy*; D006526:Hepatitis C / Q000097:blood; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000097:blood; D008108:Liver Diseases, Alcoholic / Q000097:blood* / Q000601:surgery; D016031:Liver Transplantation; D013695:Temperance; D014168:Transferrin / Q000031:analogs & derivatives* / Q000032:analysis*
chemical_list: D014168:Transferrin; C056759:carbohydrate-deficient transferrin